NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)

The NIAMS P30 Centers Program is a federal funding opportunity administered by the National Institutes of Health within the U.S. Department of Health and Human Services, specifically through the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This program is designed to support the development and enhancement of integrated research centers that align with NIAMS mission areas, including skin biology and diseases, bone, muscle and orthopedic research, and rheumatic diseases. The initiative reflects NIH’s broader commitment to advancing biomedical research infrastructure and fostering interdisciplinary collaboration to accelerate scientific discovery and improve health outcomes. The primary purpose of the program is to provide coordinated research infrastructure that enables investigators to conduct high-quality basic, translational, and clinical research. Funded centers are expected to offer shared resources, core facilities, and methodological expertise that support a wide range of research activities. These centers must integrate advanced technologies and capabilities, including data science, artificial intelligence, and implementation research, to enhance research efficiency and promote innovation. The program emphasizes the importance of developing, testing, and disseminating new analytical methods, study designs, and outcome measures that can be applied across disciplines. Funding under this opportunity supports the establishment and operation of research centers rather than individual research projects. Allowable uses of funds include the development and maintenance of shared research cores, administrative infrastructure, and training activities. Centers are also expected to support workforce development across multiple career stages, including early-career investigators and trainees. The program does not allow clinical trials, and applicants must design their proposals accordingly. There is no cost sharing or matching requirement associated with this opportunity. Eligibility for the program is broad and inclusive, encompassing a wide range of organizational types. Eligible applicants include state and local governments, public and private institutions of higher education, nonprofit organizations with or without 501(c)(3) status, for-profit organizations, small businesses, tribal governments and organizations, and certain federal agencies. Additionally, non-domestic entities and foreign institutions are eligible to apply, reflecting the program’s openness to international collaboration. Faith-based and community-based organizations may also participate if they meet the program requirements. The application process is expected to follow standard NIH submission procedures, requiring applicants to prepare and submit detailed proposals outlining their center structure, research focus, core facilities, and administrative plans. Applications will likely be submitted through Grants.gov and NIH systems, and must include comprehensive documentation demonstrating the applicant’s capacity to manage a multidisciplinary research center. While specific evaluation criteria are not detailed in the forecast, NIH typically assesses applications based on scientific merit, innovation, investigator qualifications, institutional environment, and overall impact. The opportunity is currently in a forecasted stage, with an estimated application due date of October 1, 2026. The estimated posting date is July 1, 2026, and awards are expected to be made by July 1, 2027, with project start dates aligned to the same timeline. Approximately 30 awards are anticipated under this program. Interested applicants are encouraged to monitor the official posting and prepare in advance. Questions can be directed to the program via email at NIAMSCentersProgram@mail.nih.gov. The program may be part of a recurring NIH funding cycle, though explicit recurrence details are not specified.